Ephraim E. Parent

708 total citations
47 papers, 465 citations indexed

About

Ephraim E. Parent is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Ephraim E. Parent has authored 47 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Radiology, Nuclear Medicine and Imaging, 17 papers in Pulmonary and Respiratory Medicine and 11 papers in Genetics. Recurrent topics in Ephraim E. Parent's work include Radiopharmaceutical Chemistry and Applications (17 papers), Prostate Cancer Treatment and Research (14 papers) and Medical Imaging Techniques and Applications (12 papers). Ephraim E. Parent is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (17 papers), Prostate Cancer Treatment and Research (14 papers) and Medical Imaging Techniques and Applications (12 papers). Ephraim E. Parent collaborates with scholars based in United States, India and Canada. Ephraim E. Parent's co-authors include David M. Schuster, John A. Katzenellenbogen, Michael J. Welch, Terry L. Sharp, Carmen S. Dence, Jonathon A. Nye, Kathryn E. Carlson, Mark M. Goodman, Amy M. Fowler and Akash Sharma and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Ephraim E. Parent

39 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ephraim E. Parent United States 13 279 214 70 61 53 47 465
Sarah Pfaff Austria 12 337 1.2× 320 1.5× 21 0.3× 161 2.6× 31 0.6× 29 627
Donna J. Affleck United States 15 369 1.3× 75 0.4× 45 0.6× 141 2.3× 40 0.8× 29 542
Chong Duan United States 12 189 0.7× 90 0.4× 126 1.8× 77 1.3× 95 1.8× 24 563
Aditya Bansal United States 14 281 1.0× 120 0.6× 42 0.6× 110 1.8× 6 0.1× 29 538
Takehiro Nishidai Japan 14 298 1.1× 233 1.1× 64 0.9× 44 0.7× 48 0.9× 39 696
PL Jager Netherlands 7 323 1.2× 141 0.7× 156 2.2× 58 1.0× 7 0.1× 23 631
DA Piers Netherlands 8 326 1.2× 153 0.7× 153 2.2× 59 1.0× 8 0.2× 25 648
Srinivasan Senthamizhchelvan United States 14 820 2.9× 581 2.7× 46 0.7× 160 2.6× 23 0.4× 26 1.1k
Geoffrey Bowers United States 8 151 0.5× 210 1.0× 69 1.0× 335 5.5× 36 0.7× 12 755
Ron Finn United States 7 274 1.0× 168 0.8× 28 0.4× 111 1.8× 5 0.1× 7 445

Countries citing papers authored by Ephraim E. Parent

Since Specialization
Citations

This map shows the geographic impact of Ephraim E. Parent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ephraim E. Parent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ephraim E. Parent more than expected).

Fields of papers citing papers by Ephraim E. Parent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ephraim E. Parent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ephraim E. Parent. The network helps show where Ephraim E. Parent may publish in the future.

Co-authorship network of co-authors of Ephraim E. Parent

This figure shows the co-authorship network connecting the top 25 collaborators of Ephraim E. Parent. A scholar is included among the top collaborators of Ephraim E. Parent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ephraim E. Parent. Ephraim E. Parent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Parent, Ephraim E., et al.. (2025). PSMA-Directed Theranostics in Prostate Cancer. Biomedicines. 13(8). 1837–1837.
3.
Parent, Ephraim E., Jason R. Young, Geoffrey B. Johnson, et al.. (2024). Assessment of hematological toxicity in patients with advanced neuroendocrine tumors and extensive/innumerable bone metastases undergoing lutetium-177 DOTATATE treatment.. Journal of Clinical Oncology. 42(3_suppl). 592–592.
4.
Parent, Ephraim E., et al.. (2024). Zirconium- 89 Labeled Antibody K1-70 for PET Imaging of Thyroid-stimulating Hormone Receptor Expression in Thyroid Cancer. Molecular Imaging and Biology. 26(5). 847–857. 3 indexed citations
5.
Sharma, Akash, et al.. (2023). FDG PET/CT and thyroid biopsy leads to neurosarcoidosis diagnosis. SHILAP Revista de lepidopterología. 18(11). 3932–3935. 1 indexed citations
6.
Parent, Ephraim E., Akash Sharma, A. Tuba Kendi, et al.. (2023). Evaluation of Hepatotoxicity from Peptide Receptor Radionuclide Therapy in Patients with Gastroenteropancreatic Neuroendocrine Tumors and a Very High Liver Tumor Burden. Journal of Nuclear Medicine. 64(6). 880–884. 4 indexed citations
7.
Parent, Ephraim E., et al.. (2023). Atypically Intense Pharmacologically Induced Brown Fat Activation on FDG PET/CT. Clinical Nuclear Medicine. 48(3). 233–236. 3 indexed citations
8.
Sharma, Akash, et al.. (2023). Incidental Airway Findings on PET/CT with18F-PSMA. Journal of Nuclear Medicine. 64(6). 993–993. 1 indexed citations
9.
Parrondo, Ricardo, et al.. (2022). Neuropsychiatric Manifestations of Lymphoma-Associated Cerebral Glucose Hypometabolism Can Be Reversed by Intensive Glucose Supplementation. SHILAP Revista de lepidopterología.
10.
Parent, Ephraim E., et al.. (2022). A Treatment Paradigm Shift: Targeted Radionuclide Therapies for Metastatic Castrate Resistant Prostate Cancer. Cancers. 14(17). 4276–4276. 7 indexed citations
11.
Parent, Ephraim E. & Amy M. Fowler. (2022). Nuclear Receptor Imaging In Vivo—Clinical and Research Advances. Journal of the Endocrine Society. 7(3). bvac197–bvac197. 4 indexed citations
12.
Jiang, Liuyan, et al.. (2022). Primary Bone Marrow Lymphoma: De Novo and Transformed Subtypes. Journal of Blood Medicine. Volume 13. 663–671.
13.
Tan, Winston, et al.. (2022). The Continuum of Metastatic Prostate Cancer: Interpreting PSMA PET Findings in Recurrent Prostate Cancer. Cancers. 14(6). 1361–1361. 7 indexed citations
14.
Bilen, Mehmet Asım, Akinyemi A. Akintayo, Yuan Liu, et al.. (2022). Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [68Ga]Ga DOTATATE PET-CT. Cancers. 14(24). 6039–6039. 7 indexed citations
15.
Sharma, Akash, et al.. (2022). FDG PET-MRI evaluation of synchronous gallbladder adenocarcinoma and POEMS syndrome. SHILAP Revista de lepidopterología. 17(11). 4294–4298.
16.
Advani, Pooja, et al.. (2021). Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients. Annals of Nuclear Medicine. 35(11). 1264–1269. 11 indexed citations
17.
Rojas, Carlos A., et al.. (2021). Asymptomatic coronavirus disease 2019 mimicking metastatic breast cancer on positron emission tomography/computed tomography imaging. SHILAP Revista de lepidopterología. 16(8). 2226–2230.
18.
Sonavane, Sushilkumar K., et al.. (2020). Co-existent Epicardial Paraganglioma and Anterior Mediastinal Thymoma. Journal of Radiology Case Reports. 14(10). 16–30. 1 indexed citations
19.
Parent, Ephraim E., Marc Benayoun, Jeffrey J. Olson, et al.. (2018). [18F]Fluciclovine PET discrimination between high- and low-grade gliomas. EJNMMI Research. 8(1). 67–67. 39 indexed citations
20.
Parent, Ephraim E., Carmen S. Dence, Terry L. Sharp, Michael J. Welch, & John A. Katzenellenbogen. (2006). Synthesis and biological evaluation of a fluorine-18-labeled nonsteroidal androgen receptor antagonist, N-(3-[18F]fluoro-4-nitronaphthyl)-cis-5-norbornene-endo-2,3-dicarboxylic imide. Nuclear Medicine and Biology. 33(5). 615–624. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026